Los Altos, California based biotech company Alto Neuroscience has officially filed with the SEC to raise $100M USD in an IPO on the New York Stock Exchange.

BriaCell Therapeutics (NASDAQ: BCTX) has announced new positive data from their Phase II clinical trial for patients with advanced breast cancer.

1nhaler has developed a sustainable single use medical inhaler capable of delivering multiple types of dry powder drugs to patients.

Scientists at Northwestern University have developed a new technology that could be a breakthrough in simulating how new drugs will affect the human body.

Founder of iconic apparel company Lululemon (NASDAQ: LULU) is putting $100M into his venture fund to find a cure for facioscapulohumeral muscular dystrophy

Berkley, California based biomaterials startup Bolt Threads has entered into a deal to go public via a SPAC with Golden Arrow Merger Corp (NASDAQ: GAMC)

There’s a new biotech startup focused on cancer research. And the way they got funded might just be the future of scientific ventures.

Radiopharmaceutical treatments for cancer is a highly exciting area of biotech that has been attracting venture capital and public markets investment.

Wall Street hedge fund manager Steve Cohen has taken another big stake in a small publicly traded biotech company called Bionomics.

Peter Thiel has quietly bet on a relatively unknown biotech company called Bionomics that is aiming to treat PTSD.